Avid Bioservices Inc (CDMO)

[PPHMVERYLONG]

"Here Bavituximab is the key to SOC for the BPs that otherwise compete against each other with the same type of molecules for the same conditions (cancers)."

The key that cannot go thru one trial where it succeeds without question. WS does not share your enthusiasm to put it mildly.